US 11149047
Aryl imidazoles for treatment of cancer
granted A61KA61K31/4745A61K31/517
Quick answer
US patent 11149047 (Aryl imidazoles for treatment of cancer) held by APTOSE BIOSCIENCES INC. expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- APTOSE BIOSCIENCES INC.
- Grant date
- Tue Oct 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/4745, A61K31/517, A61K31/555, A61K45/06